New push for stricter chemical laws to shield kids from harmful exposure

Research highlights the rising impact of synthetic chemicals on children’s health, linking them to noncommunicable diseases and advocating for stringent global regulations.

Samsung Biologics inks $668m manufacturing deal with European pharma – Pharmaceutical Technology

Samsung Biologics is set to add antibody-drug conjugate (ADC) services to its portfolio in this new partnership. Credit: T. Schneider via Shutterstock. Samsung Biologics has

November 21, 2024

Massachusetts’ plan for $1B in life science investment stalls in state legislature

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 3, 2024

Butterfly, Mendaera Partner to Transform Interventional Care with AI-Powered Robots

What You Should Know: – Butterfly Network (BFLY), a provider of portable ultrasound technology, and Mendaera, a Silicon Valley robotics innovator, are teaming up to

December 20, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.